Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2019-09-06

Clinical Trial Update: Impact of Emergency Department Probiotic (LGG) Treatment of Pediatric Gastroenteritis [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update on the use of emergency department probiotic treatment (LGG) for pediatric gastroenteritis completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lactobacillus rhamnosus GG (LGG) (Lactobacillus rhamnosus GG)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Gastroenteritis | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2019-09-06